Oppenheimer has recently reiterated Arvinas Inc (ARVN) stock to Outperform rating, as announced on February 28, 2024, according to Finviz. Earlier, on February 14, 2024, Citigroup had reduced the stock from a Buy to Neutral, setting a price target of $55 for ARVN stock. Goldman also initiated Buy rating with a price target of $70. Additionally, Wells Fargo raised Overweight rating on December 19, 2023, with a target price of $63. Jefferies analysts, in their report published on December 6, 2023, also raised Buy rating and set a price target of $40 for Arvinas Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
Arvinas Inc (ARVN) Stock Trading Recap
On Wednesday, Arvinas Inc (ARVN) stock saw a modest uptick, ending the day at $27.66 which represents a slight increase of $0.16 or 0.58% from the prior close of $27.5. The stock opened at $27.7 and touched a low of $27.57 during the day, reaching a high of $29.61. The volume of shares traded was 0.85 million exceeding the average volume of 0.60 million.
ARVN Stock Performance and Moving Averages
In recent trading, Arvinas Inc (ARVN) stock price has shown some volatility, fluctuating 4.30% over the last five trades and 11.17% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -14.84%, and it has gained 3.29% in the previous three months. Currently, ARVN is trading at 5.54%, 8.21%, and -15.14% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, ARVN, a Healthcare sector stock, is trading -47.89% below its 52-week high but remains 97.23% above its 52-week low. The Average True Range (ATR) (14 days) of 1.34 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Arvinas Inc’s Profitability and Valuation Ratios
Arvinas Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -397.64% and a profit margin of -346.62%, with a gross margin of -14.84%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Arvinas Inc’s market capitalization stands at $1.90 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 20.35, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 3.16, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 13.42% of Arvinas Inc (ARVN)’s shares, while financial institutions hold 99.23%.
Notable insider trades include Houston John G, President and CEO at Arvinas Inc (ARVN), who sold 5196 shares on Feb 23 ’24, at $47.05 each, totaling $0.24 million.